-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Amrize, Raises Price Target to $53

Benzinga·11/03/2025 21:21:36
Listen to the news
UBS analyst Marcus Cole maintains Amrize (NYSE:AMRZ) with a Neutral and raises the price target from $52 to $53.